C-reactive protein: A promising biomarker in ALS?
Rev Neurol (Paris)
.
2018 Mar;174(3):104-105.
doi: 10.1016/j.neurol.2017.07.001.
Epub 2017 Aug 7.
Authors
P Corcia
1
,
H Blasco
2
,
S Beltran
3
,
C Andres
2
,
P Vourc'h
2
,
P Couratier
4
Affiliations
1
Centre SLA, CHU Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 1, France. Electronic address: corcia@med.univ-tours.fr.
2
Laboratoire de Biochimie et Biologie moléculaire, 2, boulevard Tonnellé, 37044 Tours cedex 1, France; Inserm U930, 2, boulevard Tonnellé, 37032 Tours, France.
3
Centre SLA, CHU Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 1, France.
4
Centre SLA, CHU de Limoges, 2, avenue Martin Luther King, 87000 Limoges, France.
PMID:
28797688
DOI:
10.1016/j.neurol.2017.07.001
No abstract available
Publication types
Editorial
MeSH terms
Amyotrophic Lateral Sclerosis / blood*
Biomarkers / blood*
C-Reactive Protein / analysis*
Humans
Predictive Value of Tests
Reproducibility of Results
Substances
Biomarkers
C-Reactive Protein